from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1595/nadB

LFCtreatmentdescriptionclass of inhibitor

-1.012

Amikacinug/mL Amikacintranslation

-1.761

Cap5-10ug/mL Capreomycintranslation

-1.775

Rox10-50 ug/mL Roxithromycintranslation

0.057

SM2-5 ug/mL Streptomycintranslation

-2.548

Tet5-10 ug/mL Tetracyclinetranslation

-0.880

Rif0.2-5ug/mL Rifampicintranscription

-0.714

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.657

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.452

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.513

CPZ10-50 ug/mL Chlorpromazinerespiration

0.603

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.240

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.226

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.693

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.497

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.475

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.258

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.758

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.063

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.916

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.478

KCN5-20 ug/mL Potassium cyaniderespiration

0.630

NaN30.2-2 mM Sodium aziderespiration

-1.168

Nigericin50 uM Nigericinrespiration

-1.174

TRC10-150 ug/mL Triclosanrespiration

0.505

TRZ10-25 ug/mL Thioridazinerespiration

0.143

Valinomycin0.5-10 uM Valinomycinrespiration

0.231

ZnSO42 mM ZnSO4respiration

-0.749

menadione6-10 ug/mL Menadionerespiration

0.333

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.226

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.065

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.259

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.680

NRP_1Non-replicating persistence stage 1dosRassociated

0.108

Amp0.2mg/mL AmpicillincellWall

0.180

Cephalexin20-100 ug/mL CephalexincellWall

-0.127

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.204

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.005

EMB10-20 ug/mL EthambutolcellWall

0.809

Eta12-40 ug/mL EthionamidecellWall

1.045

INH0.2-0.4 ug/mL IsoniazidcellWall

0.366

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.966

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.985

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.060

BZA0.12 mg/mL BenzamidearomaticAmides

-0.079

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.360

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.079

H2O24 mM hydrogen peroxideDNAdamaging

-0.579

Levo10 ug/mL LevofloxacinDNAdamaging

-0.159

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.094

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.041

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.014

UVUV-irradiationDNAdamaging

0.871

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.009

Antimycin12.5-50 ug/mL Antimycin A?

-0.436

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.473

PA_110-50 ug/mL Antitubercular compound PA-1?

0.124

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.913

PA8240.2-2 ug/mL PA-824?

2.632

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.037

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.357

Verapamil50 uM Verapamil?

-0.651

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.499

methoxatin10-20 ug/mL Methoxatin?